Accession Number: | 0001209191-19-045880 |
Date: | 2019-08-12 |
Issuer: | SOLID BIOSCIENCES INC. (SLDB) |
Original Submission Date: |
GANOT ILAN
C/O SOLID BIOSCIENCES INC.
141 PORTLAND STREET, 5TH FLOOR
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2019-08-12 | deemed execution date | A | 1,600 (a) | common stock 1,600 | $0.00 | 1,600 | indirect | wife |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of solid biosciences inc. common stock. |
f2 | the restricted stock units vest in two equal installments on february 12, 2020 and august 12, 2020. vested shares will be delivered to the reporting person on the applicable vesting date. |